iBio (IBIO) Gross Profit (2020 - 2022)
iBio (IBIO) posted quarterly Gross Profit of $46000.0 for Q2 2022, down 84.87% year-over-year from $304000.0 in Q2 2021, and down 97.57% quarter-over-quarter from $1.9 million in Q1 2022.
iBio (IBIO) Gross Profit (2020 - 2022) Analysis & Trends
iBio (IBIO) has reported Gross Profit for 3 consecutive years, with $46000.0 the latest figure, recorded in Q2 2022.
- In Q2 2022, Gross Profit fell 84.87% year-over-year to $46000.0; the TTM figure through Jun 2022 stood at $2.2 million (up 57.83% YoY), while the FY2022 annual figure was $2.2 million, up 138.39% from the prior year.
- Gross Profit eased to $46000.0 in Q2 2022 per IBIO's latest filing, from $1.9 million in the prior quarter.
- Across five years, Gross Profit topped out at $1.9 million in Q1 2022 and bottomed at $10000.0 in Q1 2020.
- Historically, Gross Profit has averaged $437100.0 across 3 years, with a median of $287500.0 in 2020.
- On a YoY basis, Gross Profit climbed as much as 2620.0% in 2021 and fell as far as 88.87% in 2021.
- iBio's Gross Profit stood at $494000.0 in 2020, then sank by 88.87% to $55000.0 in 2021, then fell by 16.36% to $46000.0 in 2022.
- Business Quant data shows IBIO's Gross Profit at $46000.0 in Q2 2022, $1.9 million in Q1 2022, and $55000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 46,000.00 |
| Jun 30, 2022 | 46,000.00 |
| Mar 31, 2022 | 1.90 Mn |
| Mar 31, 2022 | 1.90 Mn |
| Dec 31, 2021 | 55,000.00 |
| Dec 31, 2021 | 55,000.00 |
| Sep 30, 2021 | 171,000.00 |
| Sep 30, 2021 | 171,000.00 |
| Jun 30, 2021 | 304,000.00 |
| Jun 30, 2021 | 304,000.00 |
| Mar 31, 2021 | 272,000.00 |
| Mar 31, 2021 | 272,000.00 |
| Dec 31, 2020 | 494,000.00 |
| Dec 31, 2020 | 494,000.00 |
| Sep 30, 2020 | 303,000.00 |
| Sep 30, 2020 | 303,000.00 |
| Jun 30, 2020 | 821,000.00 |
| Jun 30, 2020 | 821,000.00 |
| Mar 31, 2020 | 10,000.00 |
| Mar 31, 2020 | 10,000.00 |